DEANNA PRATT: Open Payments
NPI 1730799560 · PRESTONSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,752 in 98 payments from 14 companies in 2025. Trend: 2023 $1,024 · 2024 $1,361 · 2025 $1,752
Food & beverage: $1,752
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 20 | $414 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $234 |
| Alkermes, Inc. | 14 | $217 |
| Lundbeck LLC | 13 | $208 |
| E.R. Squibb & Sons, L.L.C. | 11 | $143 |
| Neurocrine BioSciences, Inc. | 7 | $131 |
| Teva Pharmaceuticals USA, Inc. | 6 | $110 |
| Janssen Pharmaceuticals, Inc | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $53 |
Products named: HETLIOZ, CAPLYTA, REXULTI, ARISTADA, FANAPT, COBENFY, INGREZZA, ABILIFY ASIMTUFII.
Industry payments across KY — which companies pay providers there.
